Search

Cosmetic and Reconstructive Surgery

The US Food and Drug Administration (FDA) has approved Allergan Inc. product Botox (botulinum toxin type A) to improve the appearance of moderate to severe glabellar lines, or furrows between the eyebrows. The approval applies to men and women 65 or younger. The FDA approved Botox in 1989 for the treatment of crossed eyes and uncontrollable blinking. In December 2000, the drug won US approval for treating abnormal head position and neck pain associated

The first study by Monreal and colleagues, was a prospective cohort follow-up study in which the primary goal was to assess the sensitivity of diagnostic work-up for occult malignancy in patients with VTE. Their extensive work-up included medical history, physical exam (included pelvic, rectal, and breast exams), laboratory tests, or chest X-ray. Cancer was diagnosed in 34 patients (3.9%) which translates into a sensitivity of identifying malignancy